 | Anavex Life Sciences Corp. | |||
| NMS : AVXL || Location: United States | ||||
$3.78-0.02 (-0.53%) |
2.08 M | 3.6 - 3.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 22.118 M |
| March 15, 2024 | 19.999 M |
| Feb. 29, 2024 | 20.020 M |
| Feb. 15, 2024 | 19.889 M |
| Jan. 31, 2024 | 20.128 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.15 | -0.11 | 25.63% |
| 09/30/2023 | -0.15 | -0.12 | 19.79% |
| 06/30/2023 | -0.17 | -0.14 | 17.65% |
| 03/31/2023 | -0.19 | -0.17 | 10.71% |
| 12/31/2022 | -0.19 | -0.17 | 12.28% |
AVXL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 82.112M | Shares Float | 79.520M |
| Short Float | 22.118M | Market Cap | 310.38M |
| Institution ownership | 32.12% | Insider ownership | 3.144% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.54 | Forward EPS | -0.64 |